|
| |
| | | 44691 | | 19.12.1983 | | Sandoz Pharmaceuticals AG | | 19.10.2007 | | | | | | | | | | | 01.12. | | | | 01.12. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Sirdalud 2 mg | Tabletten | Tabletten (Tizanidinum 2 mg) | M03BX02 | PI | | 02 | Sirdalud 4 mg | Tabletten | Tabletten (Tizanidinum 4 mg) | M03BX02 | PI |
|
|
|
